Al-Beltagi M. Clinical hypnosis in pediatric care: An adjunctive tool or therapeutic illusion. World J Exp Med 2025; 15(4): 114554 [DOI: 10.5493/wjem.v15.i4.114554]
Corresponding Author of This Article
Mohammed Al-Beltagi, MD, PhD, Chairman, Consultant, Head, Professor, Department of Pediatrics, Faculty of Medicine, Tanta University, 1 Hassan Radwan Street, Tanta 31511, Algharbia, Egypt. mbelrem@hotmail.com
Research Domain of This Article
Pediatrics
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Dec 20, 2025 (publication date) through Dec 19, 2025
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Experimental Medicine
ISSN
2220-315x
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Al-Beltagi M. Clinical hypnosis in pediatric care: An adjunctive tool or therapeutic illusion. World J Exp Med 2025; 15(4): 114554 [DOI: 10.5493/wjem.v15.i4.114554]
World J Exp Med. Dec 20, 2025; 15(4): 114554 Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.114554
Clinical hypnosis in pediatric care: An adjunctive tool or therapeutic illusion
Mohammed Al-Beltagi
Mohammed Al-Beltagi, Department of Pediatrics, Faculty of Medicine, Tanta University, Tanta 31511, Algharbia, Egypt
Mohammed Al-Beltagi, Department of Paediatrics, University Medical Center, King Abdullah Medical City, Arabian Gulf University, Manama 26671, Bahrain
Author contributions: Al-Beltagi M is the sole author of this review article; Al-Beltagi M was responsible for the conception, literature review, drafting, critical revision, and final approval of the manuscript.
Conflict-of-interest statement: The author declares that there are no conflicts of interest regarding the publication of this manuscript.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mohammed Al-Beltagi, MD, PhD, Chairman, Consultant, Head, Professor, Department of Pediatrics, Faculty of Medicine, Tanta University, 1 Hassan Radwan Street, Tanta 31511, Algharbia, Egypt. mbelrem@hotmail.com
Received: September 23, 2025 Revised: October 1, 2025 Accepted: November 26, 2025 Published online: December 20, 2025 Processing time: 87 Days and 18.9 Hours
Abstract
Clinical hypnosis has been proposed as a non-pharmacological intervention in pediatric healthcare, drawing on children’s natural capacity for imagination and focused attention. It has been applied across a broad spectrum of medical and psychological conditions, yet its true clinical value remains a matter of debate. This narrative review synthesizes findings from randomized controlled trials, cohort studies, systematic reviews, and clinical case series on pediatric hypnotherapy. Literature was selected based on relevance, methodological quality, and diversity of application. Evidence suggests that pediatric hypnosis may reduce acute and chronic pain, support management of functional gastrointestinal disorders, alleviate anxiety and habit disorders, improve sleep, and provide symptom relief in chronic diseases such as cancer and cystic fibrosis. Techniques are individualized and developmentally tailored, often using guided imagery, storytelling, and self-hypnosis. Reported benefits include reduced symptom burden, decreased reliance on medications, and improved quality of life. However, the strength of evidence varies considerably across conditions. Limitations include a shortage of large-scale trials, variability in individual responsiveness, limited availability of trained clinicians, and ongoing skepticism from healthcare providers and caregivers. While pediatric hypnosis may show promise as a safe and empowering adjunctive therapy, its clinical efficacy remains to be firmly established across all conditions. Further large-scale, methodologically rigorous research is required to clarify its actual benefits, cost-effectiveness, and role within integrative, evidence-based pediatric care.
Core Tip: Clinical hypnosis has emerged as a developmentally appropriate, non-pharmacological tool with potential applications across pediatric medicine. Evidence suggests benefits in acute and chronic pain, functional gastrointestinal disorders, anxiety, habit disorders, and supportive care in chronic illness. By engaging children’s imagination and suggestibility, hypnotherapy may promote self-regulation, reduce symptom burden, and improve quality of life. However, the evidence base remains uneven—strong in some domains but limited or preliminary in others. Misconceptions, limited training opportunities, and response variability hinder wider use. Further large-scale trials and standardized protocols are required to clarify whether hypnosis is a proven therapeutic tool or primarily a promising adjunct.